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Abstract
Arboviruses with neuroinvasive potential are gaining more attention due to the increased number of cases of autochthonous and imported
infections in the human host. Diagnosis of infection caused by these viruses in patients with central nervous system (CNS) diseases is still
underestimated and these infections represent an emerging threat to public health. We describe a model suitable for the laboratory
surveillance of neuro-arbovirosis that was applied in the Emilia-Romagna region, north-eastern Italy, during the 2012 summer season. One
hundred and twenty cases of suspected neuroinvasive infection were tested for arboviral agents on the basis of clinical and laboratory signs
and epidemiological data. The most common virus detected was Toscana virus (TOSV): anti-TOSV speciﬁc antibodies or viral components
were detected in 28.3% of the cases; 79.4% of the TOSV cases were in the acute phase of infection. No cases resulted in acute phase for
West Nile (WNV), Usutu (USUV), Chikungunya (CHIKV) or Dengue (DENV) virus infection. Conversely, two patients with a history of
staying in a tick-borne encephalitis virus (TBEV) endemic area showed a probable TBEV infection. These results emphasize the importance
of a complete and ‘ready to act’ laboratory diagnostic system to be implemented within the larger frame of a regional integrated surveillance
system.
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Introduction
New infectious diseases are continuously emerging and
affecting the human population; among them, vector-transmit-
ted infections pose an increasing threat to global health and
welfare [1]. Arthropod-borne viruses (arboviruses) are gen-
erally RNA viruses and can cause infections that vary from mild
forms to major symptoms; symptomatic cases may develop a
neuroinvasive disease [2]. Infections caused by RNA viruses
with neuroinvasive potential are emerging for several reasons,
including (i) the expansion of viruses to new geographical
regions, (ii) spreading from animal reservoirs, and (iii) acqui-
sition of increased neurovirulence by a previously non-neuro-
tropic virus [2]. In general, neuroinvasive infections are an
important, but likely under-diagnosed cause of neurological
disease in many developing countries [3]. The constant
increase of these infections in both developing and industri-
alized countries emphasizes the need for correct and prompt
surveillance as well as for a continuous evolution of the
diagnostic procedures.
In recent years, infections caused by neuroinvasive arbovi-
ruses have emerged in Italy, and in particular in the
north-eastern part of the country. The ﬁrst human cases of
neuroinvasive West Nile virus (WNV) infection appeared in
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the Emilia-Romagna region in 2008 [4], subsequently spreading
to other areas of the country such as Veneto, central Italy and
Sardinia [5–7]. In 2009, Usutu virus (USUV) was detected in
local birds and mosquitoes in the Emilia-Romagna region [8]
and has been identiﬁed as the cause of neurological disease in
an immunocompromised patient [9], and as inducer of
asymptomatic infections [10]. Also, Toscana virus (TOSV), a
phlebovirus causing aseptic meningitis, currently circulates in
the Emilia-Romagna region [11], in Tuscany [12] and in
southern Italy [13]. Finally, tick-borne encephalitis virus
(TBEV) is endemic in north-eastern Italy, speciﬁcally in the
Provinces of Trento, Bolzano, Belluno, Pordenone, Udine,
Treviso and Vicenza, where a rise in human cases has been
recently reported [14].
To face the increasing circulation of arboviruses, including
those causing neurological symptoms, the Regional Reference
Centre for Microbiological Emergencies (CRREM) of the Unit
of Clinical Microbiology at the St Orsola-Malpighi University
Hospital in Bologna, Italy, has developed and is continuously
improving a dedicated laboratory surveillance scheme. The
ﬁrst active regional programme for surveillance of arboviral
infection started in summer 2007 to face an outbreak of the
Aedes albopictus-transmitted Chikungunya virus (CHIKV) in a
narrow area of the Emilia-Romagna region [15]; this pro-
gramme involved clinicians, general practitioners, virologists
and public health personnel. After this episode, diagnostic
procedures have been continuously evolved on the basis of
data obtained from an integrated surveillance system that
included constant entomological, veterinary and human mon-
itoring [16] (Emilia-Romagna region website: www.saluter.it,
last accessed 24 July 2013). The Regional surveillance program
has been expanded to include WNV and Dengue virus
(DENV). TOSV, USUV and TBEV infection were also included
in our diagnostic work ﬂow.
The aim of this study is to present the surveillance protocol
for arboviruses that has been implemented as a prototype
paradigm to promptly identify emerging neuro-arbovirosis.
Results obtained during the time-frame June–November 2012
are described.
Materials and Methods
Setting and samples
In accordance with the Regional surveillance program (http://
www.saluter.it/, last accessed on 24 July 2013), clinical
samples were sent to the CRREM laboratory during a 5-
month surveillance period (June–November 2012) that over-
lapped with the peak period of arthropod vector activity.
Samples obtained from 120 patients were sent from clinical
centres located in the Emilia-Romagna region. A form
accompanying the sample, including demographic information
and reporting of the onset of the disease and symptoms,
travel history and previous vaccination, was ﬁlled in by the
physician who was responsible for the patient. The presenting
clinical features were fever, aseptic meningitis and meningo-
encephalitis. Suggestive symptoms for DENV or CHIKV
infection, such as rash, arthralgia, retro-orbital pain, haemor-
rhagic symptoms and/or thrombocytopenia, were also
reported. Samples were collected and immediately shipped
under refrigerated conditions (4°C) to the CRREM labora-
tory.
Molecular testing for arboviruses
Nucleic acids of arboviruses were detected in plasma/serum
and/or in cerebrospinal ﬂuid (CSF) specimens by using
homemade molecular methods (see Table 1 for details).
Detection of RNA was performed by real-time RT PCR for
TOSV [17], TBEV [18], WNV [19,20], USUV [21] and
CHIKV [22] or by a multiplex real-time RT-PCR for DENV
[23].
Serological testing for arboviruses
Serological tests included detection of speciﬁc IgG and IgM in
CSF and or in serum/plasma samples by commercially available
kits (Table 1). Speciﬁcally, anti-TOSV, anti-CHIKV, anti-WNV,
anti-TBEV and anti-DENV IgG and IgM were detected by using
an indirect immunoﬂuorescence (IIF) assay (Euroimmun,
L€ubeck, Germany), while DENV non-structural protein
(NS1) was measured by an enzyme immunoassay (Platelia
Dengue NS1 AG Kit; Biorad, Segrate, Italy).
Results
Protocol for laboratory surveillance activity
Figure 1 depicts the diagnostic work ﬂow that was performed
in all cases of suspected neuro-arbovirosis during the surveil-
lance period. First, speciﬁc protocols for West Nile neuroin-
vasive disease (WNND), for TOSV and for USUV infection
were implemented on CSF and/or on plasma/serum samples:
this starting point was selected given the circulation of these
viruses in the north-eastern part of the country. Laboratory
conﬁrmation of WNV entails molecular and serological testing
[24]. Conversely, because there are no data about the
persistence of TOSV in the CSF, the duration of viraemia
and the timing of the appearance of antibodies following the
onset of infection, molecular and serological methods were
simultaneously performed to identify infection caused by this
phlebovirus.
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Further, in the presence of clinical and epidemiological
criteria suggestive for DENV and/or CHIKV infection, molec-
ular and serological testing for these Aedes-transmitted viruses
was performed. Finally, in the presence of recent history of
staying in TBEV-endemic areas, speciﬁc serological and
molecular assays were carried out.
Laboratory surveillance: results of the summer-autumn 2012
activity
A total of 120 cases of suspected neuroinvasive infection were
tested for arboviral agents. The mean age of the patients was
48 years (range 5–84); 64.2% of patients were male. In 38 out
of 120 (31.7%) cases, plasma/serum and/or CSF samples tested
positive for present or past infection caused by arboviruses
(see Table 1 for detailed results). The most common infection
detected was TOSV: in 34 out of 120 cases (28.3%)
anti-TOSV-speciﬁc antibodies or viral components were
detected. In detail, 27 out of 34 cases (79.4%) were in the
acute phase of TOSV infection; seven out of 34 (20.6%) tested
positive for TOSV RNA in CSF and negative for speciﬁc
antibodies in serum/plasma, while 20 of 34 (58.8%) tested
positive both for TOSV RNA in CSF and for anti-TOSV-spe-
ciﬁc IgG and/or IgM in the corresponding serum/plasma
sample. Moreover, two (5.9%) out of 34 cases were positive
for speciﬁc IgG and IgM in serum and one (2.9%) case was IgM
positive and IgG negative in the absence of virus detection in
the CSF; these three cases were judged as recent TOSV
infection. Finally, four out of 34 cases (11.8%) tested positive
for IgG anti-TOSV and were considered as TOSV past
infection. Patients with acute/recent TOSV infection had an
age range of 16–83 years; 23 out of 30 were male.
During the 2012 surveillance, no cases of acute WNV
infection were detected, while one (0.8%) case out of 120
exhibited anti-WNV IgG and was judged as past ﬂavivirus
infection.
Chikungunya virus and DENV protocols were also applied
in seven cases that presented a history of staying in CHIKV/
DENV-endemic areas and suggestive symptoms for these
infections; no cases of active DENV or CHIKV infection were
detected, while one out of 120 cases (0.8%) tested positive for
DENV-speciﬁc IgG and was judged as past ﬂavivirus infection.
Finally, two additional cases tested positive at ﬁrst for
anti-WNV or anti-DENV IgG, respectively. As these patients
had a history of recently staying in a TBEV-endemic area
(Province of Trento), the TBEV protocol was also performed;
positive results for anti-TBEV-speciﬁc IgG and IgM were
detected in CSF and serum/plasma of both patients and the
cases were judged as probable TBEV infection. Positive
antibody tests for other ﬂaviviruses in these cases were
therefore judged as cross-reactive antibodies within the
ﬂavivirus group interfering with the test system.
Discussion
Arboviruses with neuroinvasive potential are gaining attention
due to the increased number of cases in the human host.
However, diagnosis of infections caused by these viruses in
TABLE 1. Diagnosis of arboviral infections: methods and results of the laboratory surveillance, summer-autumn 2012
Arboviruses
causing
neuro-invasive
infection CHIKV DENV TBEV TOSV USUV WNV
Acute infection
(RT-PCR+, RT-PCR
+/IgM+, RT-PCR+/IgG
+/IgM+)
0 0 0 27a 0 0
Recent infection (IgM+,
IgG+/IgM+)
0 0 2b 3 0 0
Past infection (IgG+) 0 1 0 4c 0 1
Molecular tests CHIKV RNA
(plasma/serum):
real-time
RT-PCR [22]
DENV RNA
(plasma/serum):
multiplex real-time
RT-PCR [23]
TBEV RNA (CSF):
real-time RT-PCR [18]
TOSV RNA (CSF):
real-time RT-PCR [17]
USUV RNA
(plasma/serum
and/or CSF):
real-time
RT-PCR [21]
WNV RNA
(plasma/serum
and/or CSF):
real-time
RT-PCR [19,20]
Serological tests CHIKV IgG-IgM
(serum/plasma):
immunoﬂuorescent
assay
DENV non-structural
protein (NS1)
(serum/plasma):
enzyme immunoassay
TBEV IgG-IgM (CSF,
serum/plasma):
immunoﬂuorescent assay
TOSV IgG-IgM
(serum/plasma):
immunoﬂuorescent assay
– WNV IgG-IgM
(CSF, serum/plasma):
immunoﬂuorescent
assay
DENV IgG-IgM
(serum/plasma):
immunoﬂuorescent
assay
CHIKV, Chikungunya virus; CSF, cerebrospinal ﬂuid; DENV, Dengue virus; TBEV, tick-borne encephalitis virus; TOSV, Toscana virus; USUV, Usutu virus.
aOne sample out of 27 also tested positive for IgG against WNV (West Nile virus).
bProbable infection.
cTwo out of four samples tested positive also for IgG-anti Cipro virus.
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patients with CNS disease is still underestimated and poses
many challenges for laboratory personnel and clinicians as well
as public health services [25]. Among autochthonous and
imported arboviruses with the capacity to induce a spectrum
of CNS diseases, the Flavivirus genus of the family Flaviviridae
consists of a group of important human pathogens including
WNV, TBEV, Japanese encephalitis virus (JEV) and DENV [26],
while the Phlebovirus genus of the family Bunyaviridae includes
TOSV as an emerging cause of aseptic meningitis in southern
Europe [27]. Furthermore, the Alphavirus CHIKV may cause
neurological involvement in selected cases [3,28]. Genetic
diversity has been detected among neuroinvasive arboviruses
circulating in Europe, as shown by the circulation of various
TOSV genotypes [29] and of two different WNV lineages
including various strains within lineage 1 [30], which may
potentially increase virulence and hamper performances of
molecular diagnostic tests [24]. Genetic variability of
arboviruses, associated with the possible emergence or
re-emergence of other vector-borne viruses, highlights the
need for continuous surveillance and for a seasonal update of
diagnostic methods to identify these infections. This is carried
out through a constant ﬂow of information from an integrated
system involving entomologists, veterinarians, public health
services and personnel from diagnostic laboratories [16].
Further, collaboration of molecular virologists is fundamental
to obtain timely sequencing of arboviruses circulating in
animals, vectors and humans.
By employing a dedicated model of laboratory surveillance
for neuro-arbovirosis during summer-autumn 2012, we
observed that 30 out of 120 (25%) of the patients with
suspected neuroinvasive infections had acute/recent TOSV
infection. This ﬁnding indicates that TOSV infection represents
a relevant health problem in the Emilia-Romagna region, in
agreement with previously published information [11] and with
epidemiology data from the surrounding Mediterranean areas
[12,13].
In addition, by applying the surveillance ﬂowchart we
diagnosed two imported cases of probable TBEV infection.
FIG. 1. Diagnostic work-ﬂow for suspected neuro-arbovirosis during the surveillance period.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, 672–677
CMI Pierro et al. Laboratory surveillance for arbovirosis 675
TBEV does not circulate in the Emilia-Romagna region but it
was included in our monitoring scheme because of its
circulation in other areas of northern Italy [14]. The identi-
ﬁcation of these two cases of TBEV infection in our patients
stresses the importance of the form accompanying the sample,
which should be correctly ﬁlled in by including detailed clinical
and epidemiological data.
An acute WNV infection could not be proven in any of the
120 cases evaluated in this study. This is surprising because the
incidence of WNND increased in a nearby area of northern
Italy during the same season [31]. Reasons for this epidemi-
ological discrepancy in the two close areas are unclear so far.
As potentially suitable vectors for WNV as well as for USUV,
CHIKV and DENV circulate in Italy, virological monitoring of
human cases potentially caused by these viruses remains
important.
Aligned to the virological work-ﬂow and to results obtained
through its application, a proactive approach to prevention and
management was implemented by public health services,
including measures of vector control (mosquitoes and sand-
ﬂies) and information given to general practitioners and
physicians in emergency departments.
The results obtained with the laboratory surveillance applied
during 2012 in the Emilia-Romagna region by using the
work-ﬂow here described emphasize the importance of an
evolving diagnostic system as arboviruses are constantly chang-
ing and both virus and host characteristics may vary over time.
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